Xcout Intel
Quest PharmaTech Inc. competitors & alternatives
The 12 closest competitors and alternatives to Quest PharmaTech Inc. among pharmaceuticals companies — ranked by similarity to what Quest PharmaTech Inc. actually does, not by market-cap band.
Subscribe to see Quest PharmaTech Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Quest PharmaTech Inc.
Quest PharmaTech Inc. is a Canadian pharmaceutical company that develops products for targeted cancer therapy, including proprietary antibodies. The company operates and invests in various biotechnology ventures, holding ownership interests in firms focused on advancing immunotherapy treatments.
Top 12 Quest PharmaTech Inc. competitors
Ranked by semantic similarity — how close each company is to Quest PharmaTech Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology & Pharmaceuticals
Creative Biolabs is a biotechnology company that provides custom antibody development, engineering, and manufacturing services for pharmaceutical and research projects.
Biotechnology, Drug Discovery
QureTech Bio is a biotechnology company that develops treatments to defeat bacterial virulence and restore antibiotic susceptibility, specifically targeting drug-resistant infections such as Staphylococcus aureus. The company serves the pharmaceutical and healthcare sectors by advancing novel antibacterial portfolios and seeking partnership opportunities.
Biotech, Pharmaceuticals
PharmAbcine Inc. is a South Korean public company and a bio venture specializing in the research and development of antibody treatments. It operates in pharmaceutical manufacturing.
Similar pharmaceuticals company
Knight Therapeutics Inc., a specialty pharmaceutical enterprise established in Montreal, Canada in 2013, operates globally, with a strong presence across Canada and Latin America. The company's core business revolves around the development, acquisition, in-licensing, out-licensing, promotion, and distribution of a diverse portfolio encompassing pharmaceutical products, consumer health goods, and medical devices. Its extensive product catalog features treatments such as Nerlynx, prescribed for extended adjuvant and metastatic breast cancer; Tafasitamab, used for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib, targeting metastatic cholangiocarcinoma; Trelstar, addressing advanced prostate cancer and pain associated with endometriosis; Vidaza, indicated for myelodysplastic syndrome; Abraxane, for metastatic pancreatic adenocarcinoma; Halaven, for metastatic breast cancer and soft tissue sarcoma; and Lenvima, useful in differentiated thyroid cancer, advanced renal cell cancer, and unresectable hepatocellular carcinoma. The company's offerings further include Ladevina, for multiple myeloma, myelodysplastic syndrome, mantle cell lymphoma, and follicular lymphoma; Zyvalix, for metastatic prostate cancer; Karfib, for relapsed or refractory multiple myeloma; Leprid, for advanced prostate cancer; and Rembre, for chronic myeloid leukemia. For infectious diseases, it provides Ambisome and Cresemba for fungal infections, along with Impavido for leishmaniasis. Other notable products include Exelon, managing mild to moderately severe dementia; Ibsrela, for irritable bowel syndrome with constipation; Salofalk, for ulcerative colitis; Ursofalk, to treat biliary cirrhosis; Imvexxy, for moderate to severe dyspareunia; Bijuva, for moderate to severe vasomotor symptoms linked to menopause in women with intact uteri; Fibridoner, for idiopathic pulmonary fibrosis; Toliscrin DPI, addressing pseudomonas aeruginosa lung infection in patients with cystic fibrosis; Toliscrin 1-2, for severe acute or resistant chronic infections; and Tobradosa Haler, for chronic lung infections. Beyond its product-focused endeavors, Knight Therapeutics Inc. also provides financing to other life science companies and makes strategic investments in life sciences venture capital funds.
Similar pharmaceuticals company
Ottimo Pharma is an innovative, clinical-stage private biotechnology company co-founded in 2020 by Medicxi and Jonny Finlay. The company is focused on developing pioneering bi-functional medicines and one-of-a-kind PD-1/VEGFR2 dual-paratopic antibodies to extend the lives of cancer patients.
Similar pharmaceuticals company
Reven Holdings Inc. is a pharmaceutical company that develops pharmacological solutions and proprietary drug formulations aimed at targeting the root cause of diseases by restoring immune system homeostasis. The company focuses on addressing inflammation-related conditions ranging from cancer to cardiovascular disease.
Biotechnology & Pharmaceuticals
Cancer Research Horizons is a specialist drug discovery, development, and commercialisation company that translates lab-bench innovations into diagnostics and treatments for cancer patients. The company collaborates with researchers, partners, and investors to advance oncology therapeutics, manage start-ups, and license research tools and data portfolios.
Biotechnology / Pharmaceuticals
Symphogen, part of the Servier Group, operates as an Antibody Center of Excellence focusing on oncology and immuno-oncology. The company utilizes an antibody discovery and research platform to develop monoclonal antibody therapeutics aimed at improving treatments for cancer patients.
Similar pharmaceuticals company
JAMP Pharma Group is a private Canadian pharmaceutical company launched in 1988 and based in the Montreal region of Quebec. Originally operating as a contract manufacturing organization, the company now actively supplies a broad range of pharmaceutical products across Canada.
Similar pharmaceuticals company
Cao Pharmaceuticals Inc. develops anti-cancer drugs utilizing natural anti-cancer compounds. The company focuses on research, product pipelines, and developing lead drug candidates for cancer treatment.
Biotechnology & Pharmaceuticals
SciTech Development L.L.C. is a clinical-stage specialty oncology pharmaceutical company that develops safer drug delivery platforms and targeted cancer therapeutics. The company's lead candidate, ST-001 nanoFenretinide, is a patented treatment designed for lymphoma and other cancer indications.
Similar pharmaceuticals company
Beijing Puqi Pharmaceutical Technology Co., Ltd., also known as Prime Gene Therapeutics, is a biotechnology company focused on treating immune-inflammatory diseases through locally delivered targeted therapies. The company's business model encompasses innovative drug research, the development of clinically valuable generic drugs, and pharmaceutical industrialization.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Quest PharmaTech Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Quest PharmaTech Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →